🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nan Li

National Institutes of Health

ORCID: 0000-0002-1498-7139

Also affiliated with Harbin Medical University, Chongqing University, Jinan University, Fourth Affiliated Hospital of Harbin Medical University, National Cancer Institute, Center for Cancer Research, Chongqing Cancer Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice”.

Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice

Gastroenterology(2020)10.1053/j.gastro.2020.02.011
N/A
0.765DataRank · unranked
163 citations

Nan Li, Yifan Zhang, Haiying Fu, Mingqian Feng, Dina Schneider +22 more

Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001875
N/A
0.713DataRank · unranked
115 citations

Fang Gao, Zhanhui Gao, Lei Ao, Na Li, Sujuan Ma +9 more

The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer

Nature Communications(2023)10.1038/s41467-023-37616-4
N/A
0.612DataRank · unranked
58 citations

Alex Quan, Dan Li, Jiajia Pan, Hua Ren, Gerard D. Hoeltzel +9 more

CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100297
N/A
0.581DataRank · unranked
47 citations

Madeline B. Torres, Madeline R. Spetz, Ruixue Wang, Luyi Peng, Meijie Tian +14 more

Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3

Pharmacology & Therapeutics(2021)10.1016/j.pharmthera.2021.107892
N/A
0.457DataRank · unranked
20 citations

Madeline R. Spetz, Dan Li, Mitchell Ho, Nan Li

Development of Glypican-2 Targeting Single-Domain Antibody CAR T Cells for Neuroblastoma

Methods in molecular biology(2022)10.1007/978-1-0716-2075-5_23
N/A
0.326DataRank · unranked
4 citations

Mitchell Ho, Nan Li

Engineered, fully human nanobody-based CAR T cells have enhanced antitumor activity against hepatocellular carcinoma in preclinical models.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e14512
N/A
0.104DataRank · unranked
1 citations

Dan Li, Nan Li, Mitchell Ho, Aarti Kolluri

Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC

Hepatology Communications(2023)10.1097/hc9.0000000000000022
N/A
0DataRank · unranked
17 citations

Dan Li, Nan Li, Zhijian Duan, Lewis R. Roberts, Mitchell Ho +1 more

Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen density

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102378
N/A
0DataRank · unranked
1 citations

Mingyu Huo, Dan Li, Laura Hutchins, Constanza Rodríguez, Jangsuk Oh +15 more

The Role of Glypicans in Cancer Progression and Therapy

Journal of Histochemistry & Cytochemistry(2020)10.1369/0022155420933709
N/A
0DataRank · unranked
88 citations

Madeline R. Spetz, Mitchell Ho, Nan Li

Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models

STAR Protocols(2021)10.1016/j.xpro.2021.100942
N/A
0DataRank · unranked
11 citations

Rosa Nguyen, Carol J. Thiele, Mitchell Ho, Nan Li

An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma

Journal of Clinical Investigation(2022)10.1172/jci155621
N/A
0DataRank · unranked
72 citations

Adam Cheuk, Jun S. Wei, Abdalla Abdelmaksoud, Hsien-Chao Chou, David Milewski +18 more

Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0073
N/A
0DataRank · unranked
46 citations

Jingli Zhang, Manakamana Khanal, Jessica Hong, Abhilash Venugopalan, Qun Jiang +7 more

GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0778
N/A
0DataRank · unranked
13 citations

Nan Li, Alex Renn, Hu Zhu, Lu Chen, Min Shen +5 more

Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005881
N/A
0DataRank · unranked
32 citations

Yingying Cao, Reona Okada, Jeyshka M. Reyes‐González, Hannah G Stack, Haiying Qin +8 more